Concepedia

Publication | Open Access

Eribulin Suppresses New Metastases in Patients With Metastatic Breast Cancer

DOIFull Paper Access

13

Citations

9

References

2020

Year

Takaaki Fujii, Shoko Tokuda, Yuko Nakazawa, Sasagu Kurozumi, Sayaka Obayashi, Reina Yajima, Ken Shirabe
In Vivo

Abstract

Eribulin has a potential antitumor mechanism to prevent new metastasis. Eribulin may be effective against both the epithelial-mesenchymal transition (EMT) process and new metastasis.

References

YearCitations

Page 1